Balversa’s FDA Approval Means a New, Practice-Changing Option for FGFR-Positive Bladder Cancer

Balversa’s FDA Approval Means a New, Practice-Changing Option for FGFR-Positive Bladder Cancer

NOW
PLAYING
A Powerful Tool: Integrating Venetoclax into CLL Management Improves Survival
NOW
PLAYING
Elahere: A Practice-Changing Option for Platinum-Resistant, FRα-Positive Ovarian Cancer
NOW
PLAYING
Rytelo Gains FDA Approval for Lower-Risk Myelodysplastic Syndrome: Reducing Need For Blood Transfusions & Improving Quality of Life
NOW
PLAYING
Criteria and Considerations for Using Newly FDA-Approved Lifileucel in Advanced Melanoma
NOW
PLAYING
Physicians Advised to Consider Rybrevant for EGFR Mutation-Positive NSCLC, Following FDA Approval
NOW
PLAYING
Tepmetko Approval for NSCLC Mutation Underscores the Value of Genetic Testing

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... bladder cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider